- Home
- RVPH vs KRMD Comparison
RVPH vs KRMD Comparison
Compare RVPH & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- KRMD
- Stock Information
- Founded
- RVPH 2006
- KRMD 1980
- Country
- RVPH United States
- KRMD United States
- Employees
- RVPH N/A
- KRMD 80
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- KRMD Medical/Dental Instruments
- Sector
- RVPH Health Care
- KRMD Health Care
- Exchange
- RVPH Nasdaq
- KRMD Nasdaq
- Market Cap
- RVPH N/A
- KRMD 111.7M
- IPO Year
- RVPH N/A
- KRMD N/A
- Fundamental
- Price
- RVPH $0.88
- KRMD $2.62
- Analyst Decision
- RVPH Strong Buy
- KRMD Strong Buy
- Analyst Count
- RVPH 5
- KRMD 4
- Target Price
- RVPH $10.00
- KRMD $4.88
- AVG Volume (30 Days)
- RVPH 937.7K
- KRMD 143.4K
- Earning Date
- RVPH 05-13-2025
- KRMD 05-07-2025
- Dividend Yield
- RVPH N/A
- KRMD N/A
- EPS Growth
- RVPH N/A
- KRMD N/A
- EPS
- RVPH N/A
- KRMD N/A
- Revenue
- RVPH N/A
- KRMD $33,646,463.00
- Revenue This Year
- RVPH N/A
- KRMD $16.50
- Revenue Next Year
- RVPH N/A
- KRMD $15.47
- P/E Ratio
- RVPH N/A
- KRMD N/A
- Revenue Growth
- RVPH N/A
- KRMD 17.98
- 52 Week Low
- RVPH $0.49
- KRMD $1.86
- 52 Week High
- RVPH $4.28
- KRMD $5.05
- Technical
- Relative Strength Index (RSI)
- RVPH 51.30
- KRMD 52.60
- Support Level
- RVPH $0.81
- KRMD $2.35
- Resistance Level
- RVPH $0.92
- KRMD $2.52
- Average True Range (ATR)
- RVPH 0.09
- KRMD 0.20
- MACD
- RVPH 0.05
- KRMD 0.08
- Stochastic Oscillator
- RVPH 88.97
- KRMD 94.23
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).